BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
105 results:

  • 1. [Analysis of factors influencing the efficacy and prognosis of surgical treatment for primary malignant pelvic bone tumors].
    Liu WF; Hao L; Li ZY; Jin T; Sun Y; Yang YK; Li Y; Yang FJ; Yu F; Zhang Q; Niu XH
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):344-353. PubMed ID: 38644270
    [No Abstract]    [Full Text] [Related]  

  • 2. Factors influencing postoperative visual improvement in 208 patients with tuberculum sellae meningiomas.
    Duan C; Song D; Wang F; Wang Y; Wei M; Fang J; Zhai T; An Y; Zuo Y; Hu Y; Li G; Yu Z; Guo F
    Acta Neurochir (Wien); 2024 Mar; 166(1):140. PubMed ID: 38491189
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Charcot neuroarthropathy in persons with diabetes: It's time for a paradigm shift in our thinking.
    Wukich DK; Frykberg RG; Kavarthapu V
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3754. PubMed ID: 38069459
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adjacent tooth migration after maxillary first molar loss in patients with sinus augmentation: A retrospective research.
    Zhao F; Shi L; Huang Y; Wang Y; Yu M; Wang H
    Clin Implant Dent Relat Res; 2023 Dec; 25(6):1080-1090. PubMed ID: 37496294
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognosis prediction of icotinib as targeted therapy for advanced EGFR-positive non-small cell lung cancer patients.
    Tan X; Wang S; Xia H; Chen H; Xu J; Meng D; Wang Z; Li Y; Yang L; Jin Y
    Invest New Drugs; 2023 Jun; 41(3):463-472. PubMed ID: 37140694
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients.
    Kadys A; Gremke N; Schnetter L; Kostev K; Kalder M
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7319-7326. PubMed ID: 36920565
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
    Hillmen P; Eichhorst B; Brown JR; Lamanna N; O'Brien SM; Tam CS; Qiu L; Kazmierczak M; Zhou K; Šimkovič M; Mayer J; Gillespie-Twardy A; Shadman M; Ferrajoli A; Ganly PS; Weinkove R; Grosicki S; Mital A; Robak T; Österborg A; Yimer HA; Salmi T; Ji M; Yecies J; Idoine A; Wu K; Huang J; Jurczak W
    J Clin Oncol; 2023 Feb; 41(5):1035-1045. PubMed ID: 36395435
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Efficacy and Safety of Radium-223 for Castration-resistant Prostate cancer With bone Metastasis Before and After Docetaxel.
    Okabe KO; Terada N; Shirakawa T; Onizuka C; Kimura T; Yamashita Y; Otuka I; Ueno T; Nagano M; Takamori H; Mukai S; Kamoto T
    Anticancer Res; 2022 Oct; 42(10):4981-4987. PubMed ID: 36191975
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
    Bielack SS; Blattmann C; Borkhardt A; Csóka M; Hassenpflug W; Kabíčková E; Kager L; Kessler T; Kratz C; Kühne T; Kevric M; Lehrnbecher T; Mayer-Steinacker R; Mettmann V; Metzler M; Reichardt P; Rossig C; Sorg B; von Luettichau I; Windhager R; Hecker-Nolting S
    Eur J Cancer; 2022 Nov; 176():50-57. PubMed ID: 36191386
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial.
    Kater AP; Levin MD; Dubois J; Kersting S; Enggaard L; Veldhuis GJ; Mous R; Mellink CHM; van der Kevie-Kersemaekers AF; Dobber JA; Poulsen CB; Frederiksen H; Janssens A; Schjødt I; Dompeling EC; Ranti J; Brieghel C; Mattsson M; Bellido M; Tran HTT; Nasserinejad K; Niemann CU
    Lancet Oncol; 2022 Jun; 23(6):818-828. PubMed ID: 35654052
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
    Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
    JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of open versus minimally invasive surgery in the treatment of thoracolumbar metastases.
    Ntilikina Y; Collinet A; Tigan LV; Fabacher T; Steib JP; Charles YP
    Orthop Traumatol Surg Res; 2022 Jun; 108(4):103274. PubMed ID: 35331924
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Research Progress of Exosome-Loaded miRNA in Osteosarcoma.
    Yao P; Lu Y; Cai Z; Yu T; Kang Y; Zhang Y; Wang X
    Cancer Control; 2022; 29():10732748221076683. PubMed ID: 35179996
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of treatment refusal and abandonment on survival outcomes in pediatric osteosarcoma in Southeast Asia: A multicenter study.
    Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Kimpo M; Dhamne C; Blair S; Lam C; Photia A; Rujkijyanont P; Traivaree C; Pairojboriboon S; Rodriguez-Galindo C;
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29556. PubMed ID: 35038209
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
    Roberts KE; Adsett IT; Rickett K; Conroy SM; Chatfield MD; Woodward NE
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013167. PubMed ID: 35005781
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
    Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
    Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mandibular Reconstruction with Scapular Systems: A Single-Center Case Series Involving 208 Flaps.
    Harada H; Shimamoto H; Oikawa Y; Kuroshima T; Tomioka H; Hirai H; Tsushima F; Michi Y
    Plast Reconstr Surg; 2021 Sep; 148(3):625-634. PubMed ID: 34432693
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
    Deng DX; Wen JJ; Cheng YF; Zhang XH; Xu LP; Wang Y; Yan CH; Chen YH; Chen H; Han W; Wang FR; Wang JZ; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
    BMC Cancer; 2021 Mar; 21(1):292. PubMed ID: 33740924
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients.
    Cybulska-Stopa B; Ziętek M; Kamińska-Winciorek G; Czarnecka AM; Piejko K; Galus Ł; Ziółkowska B; Kieszko S; Kempa-Kamińska N; Calik J; Zemełka T; Kubiatowski T; Suwiński R; Mackiewicz J; Rutkowski P
    Melanoma Res; 2021 Feb; 31(1):49-57. PubMed ID: 33165240
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.